Psychiatric and sexual disorders induced by apomorphine in Parkinson's disease. 1997

E Courty, and F Durif, and M Zenut, and P Courty, and J Lavarenne
Department of Psychiatry, Clermont-Ferrand, France.

A similar pattern of psychosexual disorders has been observed after long-term treatment with levodopa therapy in four male parkinsonian patients treated with apomorphine for severe on-off motor fluctuations. An acute episode in each case had led them to the hospital in the context of a psychiatric emergency (after punishable sexual acts in two cases). In each case, this episode had been preceded by an increase of self-administered apomorphine, whereas other antiparkinsonian drugs remained unchanged. Questioning had revealed psychosexual disturbances as early as the onset of apomorphine treatment, which tended to progressively worsen with the number of apomorphine daily doses. A decrease in the dosage of apomorphine had been followed by the improvement of the psychiatric condition without worsening of the motor status. Recurrence of psychiatric disorders with similar features had been observed when two patients again increased the number of apomorphine daily injections. The absence of somatic manifestations when apomorphine treatment was withdrawn or reduced, with persistence of psychosexual disturbances, could suggest a psychological dependence from the drug.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000978 Antiparkinson Agents Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. Antiparkinson Drugs,Antiparkinsonian Agents,Antiparkinsonians,Agents, Antiparkinson,Agents, Antiparkinsonian,Drugs, Antiparkinson
D001058 Apomorphine A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use. Apokinon,Apomorphin-Teclapharm,Apomorphine Chloride,Apomorphine Hydrochloride,Apomorphine Hydrochloride Anhydrous,Apomorphine Hydrochloride, Anhydrous,Apomorphine Hydrochloride, Hemihydrate,Britaject,Apomorphin Teclapharm
D012646 Self Administration Administration of a drug or chemical by the individual under the direction of a physician. It includes administration clinically or experimentally, by human or animal. Administration, Self,Administrations, Self,Self Administrations
D018491 Dopamine Agonists Drugs that bind to and activate dopamine receptors. Dopamine Receptor Agonists,Dopaminergic Agonists,Agonists, Dopamine Receptor,Agonists, Dopaminergic,Dopamine Agonist,Dopamine Receptor Agonist,Dopaminergic Agonist,Receptor Agonists, Dopamine,Agonist, Dopamine,Agonist, Dopamine Receptor,Agonist, Dopaminergic,Agonists, Dopamine,Receptor Agonist, Dopamine
D020018 Sexual Dysfunctions, Psychological Disturbances in sexual desire and the psychophysiologic changes that characterize the sexual response cycle and cause marked distress and interpersonal difficulty. (APA, DSM-IV, 1994) Frigidity,Hypoactive Sexual Desire Disorder,Orgasmic Disorder,Psychosexual Disorders,Psychosexual Dysfunctions,Sexual Arousal Disorder,Sexual Aversion Disorder,Arousal Disorders, Sexual,Aversion Disorders, Sexual,Disorder, Psychosexual,Disorders, Orgasmic,Disorders, Psychosexual,Disorders, Sexual Arousal,Disorders, Sexual Aversion,Dysfunction, Psychological Sexual,Dysfunction, Psychosexual,Dysfunctions, Psychological Sexual,Dysfunctions, Psychosexual,Orgasmic Disorders,Psychological Sexual Dysfunction,Psychological Sexual Dysfunctions,Psychosexual Disorder,Psychosexual Dysfunction,Sexual Arousal Disorders,Sexual Aversion Disorders,Sexual Dysfunction, Psychological

Related Publications

E Courty, and F Durif, and M Zenut, and P Courty, and J Lavarenne
August 1994, Journal of neurology, neurosurgery, and psychiatry,
E Courty, and F Durif, and M Zenut, and P Courty, and J Lavarenne
May 1998, Movement disorders : official journal of the Movement Disorder Society,
E Courty, and F Durif, and M Zenut, and P Courty, and J Lavarenne
January 1992, British journal of hospital medicine,
E Courty, and F Durif, and M Zenut, and P Courty, and J Lavarenne
January 1993, British journal of hospital medicine,
E Courty, and F Durif, and M Zenut, and P Courty, and J Lavarenne
January 2001, Functional neurology,
E Courty, and F Durif, and M Zenut, and P Courty, and J Lavarenne
April 2000, Annals of neurology,
E Courty, and F Durif, and M Zenut, and P Courty, and J Lavarenne
February 1998, Neurophysiologie clinique = Clinical neurophysiology,
E Courty, and F Durif, and M Zenut, and P Courty, and J Lavarenne
January 1951, Transactions of the American Neurological Association,
E Courty, and F Durif, and M Zenut, and P Courty, and J Lavarenne
November 1996, Movement disorders : official journal of the Movement Disorder Society,
E Courty, and F Durif, and M Zenut, and P Courty, and J Lavarenne
December 1989, Journal of neurology, neurosurgery, and psychiatry,
Copied contents to your clipboard!